CIRM

“Solomonic” CIRM Proposal: Institutional Board Members Would not Vote on Grants

I just received a copy of CIRM’s proposed response to the IOM recommendations. Regarding what I believe to be the most important element, revamping the CIRM Board (aka ICOC), I was interested to see that CIRM (via President Jonathan Thomas) recommended that all institutional members of the Board no longer vote on whether to fund …

“Solomonic” CIRM Proposal: Institutional Board Members Would not Vote on Grants Read More »

Live Blogging the CIRM Board meeting on the IOM report

I made it here in one piece to Berkeley at the Claremont Hotel driving through torrential rain to get here for the CIRM Board Meeting discussing the recent Institute of Medicine (IOM) report on CIRM. The Board is in intensive discussion as I type. Some members seem more in favor of change and others are …

Live Blogging the CIRM Board meeting on the IOM report Read More »

California pays its sports coaches alone more than the entire payroll of CIRM

CIRM-

There has been a largely media-fed hullabaloo about the salary for the new Chair of CIRM, the California Institute for Regenerative Medicine, $400,000. Now don’t get me wrong, that sounds like a lot of money to me personally, but we need to put it in perspective and when we do, the salary is reasonable and …

California pays its sports coaches alone more than the entire payroll of CIRM Read More »

CIRM funds $25 million for Geron trial, $38 million for basic biology

Geron-300x2212

CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company …

CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »

Why scientists must be advocates too: Jeff Sheehy

Jeff-Sheehy

CIRM Board Member, Jeff Sheehy, has a wonderful piece in Nature Medicine on why patient advocates play a critical role in decision making on research priorities (hat tip to Amy Adams who first blogged on Sheehy’s piece). Patient advocates bring a unique and valuable perspective to the table. Their role in guiding CIRM research funding …

Why scientists must be advocates too: Jeff Sheehy Read More »

Grim reality of the impact of judge’s ES cell decision is emerging

Francis-Collins-ES-cell-research-lawsuit

The Obama administration has announced it will “quickly” appeal the ES cell decision, but I’m not hearing anything about a stay on the judge’s order in the meantime or anything like that. It’s quite the opposite. The NIH, in the form of Director Francis Collins, has finally spoken about the federal judge’s ruling that apparently banned …

Grim reality of the impact of judge’s ES cell decision is emerging Read More »